Status:
COMPLETED
Treatment Decision-making in Patients With Recurrent High-grade Glioma
Lead Sponsor:
Odense University Hospital
Collaborating Sponsors:
Rigshospitalet, Denmark
Region of Southern Denmark
Conditions:
Malignant Glioma
Life Experiences
Eligibility:
All Genders
18+ years
Brief Summary
This qualitative study explores the lived experience of high-grade glioma patients and their close relatives at time of recurrence. With focus on the decision-making about treatment and care..
Detailed Description
High-Grade Glioma is a life-threatening disease that can cause the patient substantial physical, mentally and psychosocially impairment. The life expectancy is short, and a majority of patients experi...
Eligibility Criteria
Inclusion
- The patient is offered surgical treatment (after an assesment done by the multidisciplinary team)
- Able to speak and understand danish
- Able to participate in an interview
- Able to give informed concent for participation
Exclusion
- Patients with severe cognitive impairment which prohibits them from either giving informed concent or participating in interview.
- Relatives are excluded if the patient do not give concent for the participation of relatives
Key Trial Info
Start Date :
May 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 8 2022
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04013828
Start Date
May 6 2019
End Date
April 8 2022
Last Update
April 20 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen University Hospital; Rigshospitalet
Copenhagen, Denmark
2
Odense University Hospital
Odense, Denmark